Although partial knee arthroplasty for anteromedial arthritis had higher reoperation rates, results presented here showed it ...

Johnson & Johnson (NYSE: JNJ) is reportedly preparing for a potential sale of its orthopedics unit, DePuy Synthes, as it advances plans to separate the business. In 2011, the medtech giant acquired ...

Johnson & Johnson joined the industry trend of shedding weight in medtech last year when it announced plans to separate its orthopedics business into a standalone company. Now, reports have emerged ...

This article first appeared on GuruFocus. Johnson & Johnson (NYSE:JNJ) is advancing preparations for a potential sale of its orthopedics division, DePuy Synthes, with several large private equity ...

Feb 19 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab is preparing a potential sale of its orthopedics unit, in a deal that could top $20 billion, with the company eyeing private equity firms as ...

After a knee replacement in 2024, Lindsey Vonn returned to Alpine ski racing that winter, launching one of the more remarkable sports comebacks ever. Marco Bertorello / AFP via Getty Images Lindsey ...

Robert (Bob) P. DePuy, High Falls, NY ‘ Robert (Bob) P. DePuy passed away peacefully on December 14, 2025 at the Golden Hill Nursing and Rehabilitation Center at the age of 91. He was born on December ...

Among individuals with medial compartment knee osteoarthritis, those who underwent partial knee replacement demonstrated clinical outcomes and rates of reoperation and revision comparable to those who ...

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D-printed, personalized orthopedic solutions, today announced the successful completion of the first clinical cases using the iTotal Identity™ CR ...

Whether partial versus total arthroplasty is the best for patients with unicompartmental osteoarthritis (OA) of the knee has long been debated. The so-called TOPKAT trial randomized patients to the ...

Two years after spinning off its $15 billion consumer health unit as Kenvue, Johnson & Johnson is slimming down again by unveiling a plan to separate its orthopedics business, transforming it into a ...

Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.